Analyst Ratings for Halozyme Therapeutics (halo)

halo Rating Summary

halo Price Target Summary

* Over Last 12-Mos
  |   Expand Research on halo
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $19.80 (+99.2%) * Over Last 12-Mos
Rating Score: 9.2 / 10   Percentile Rank: 92%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
2/1/2016 Canaccord Genuity New Coverage Buy
(N/A)
10.00
(N/A)
8.80 9.94 12.95% Details
12/4/2015 Wells Fargo New Coverage Outperform
(N/A)
N/A
(N/A)
17.62 9.94 -43.59% Details
Like HALO Ratings? Also take a look at LLY, ABBV

HALO Ratings News